Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Lupus 2012: New targets, new approaches

Meeting abstract

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?

A Thanou, M Munroe, S Kamp, F Carthen, JA James and JT Merrill*

  • * Corresponding author: JT Merrill

Arthritis Research & Therapy 2012, 14(Suppl 3):A47  doi:10.1186/ar3981

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 50 accesses
  • Last 365 days: 443 accesses
  • All time: 895 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information